n-benzyladriamycin-14-valerate has been researched along with ellipticine in 1 studies
| Studies (n-benzyladriamycin-14-valerate) | Trials (n-benzyladriamycin-14-valerate) | Recent Studies (post-2010) (n-benzyladriamycin-14-valerate) | Studies (ellipticine) | Trials (ellipticine) | Recent Studies (post-2010) (ellipticine) |
|---|---|---|---|---|---|
| 25 | 0 | 3 | 454 | 0 | 178 |
| Protein | Taxonomy | n-benzyladriamycin-14-valerate (IC50) | ellipticine (IC50) |
|---|---|---|---|
| Cytochrome P450 1A1 | Homo sapiens (human) | 0.0193 | |
| Mast/stem cell growth factor receptor Kit | Homo sapiens (human) | 0.2 | |
| DNA topoisomerase 2-alpha | Homo sapiens (human) | 3.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Darzynkiewicz, Z; Kapuscinski, J; Traganos, F | 1 |
1 other study(ies) available for n-benzyladriamycin-14-valerate and ellipticine
| Article | Year |
|---|---|
Caffeine modulates the effects of DNA-intercalating drugs in vitro: a flow cytometric and spectrophotometric analysis of caffeine interaction with novantrone, doxorubicin, ellipticine, and the doxorubicin analogue AD198.
Topics: Acridine Orange; Animals; Caffeine; Cell Cycle; Cell Division; Doxorubicin; Drug Interactions; Ellipticines; Flow Cytometry; Mice; Mitoxantrone; Nucleic Acids; Spectrophotometry | 1991 |